Taking antidepressants in pregnancy harms the foetus more than you know

Women who take antidepressants during their early pregnancy may significantly raise the risk of delivering a stillborn or a baby with birth defects, warns a new study.
Women who are prescribed selective serotonin reuptake inhibitors in the first trimester or three months before pregnancy are at a small but significantly great risk of having infants with congenital anomalies.(Shutterstock)
Women who are prescribed selective serotonin reuptake inhibitors in the first trimester or three months before pregnancy are at a small but significantly great risk of having infants with congenital anomalies.(Shutterstock)
Updated on Dec 07, 2016 04:17 PM IST
Copy Link
By IANS, London

Women who take antidepressants during their early pregnancy may significantly raise the risk of delivering a stillborn or a baby with birth defects, warns a new study.

The findings revealed that the women who had been prescribed selective serotonin reuptake inhibitors, known as SSRIs, in the first trimester of pregnancy or three months before pregnancy were at a small but significantly greater risk of having infants with congenital anomalies — particularly severe heart defects or stillbirths.

“We are not saying stop all medicines, but our message is that we want our health care professionals to be very mindful of this link and to take the appropriate action to ensure that women are given the right type of care before, during and after pregnancy to minimise the risks of congenital anomalies and stillbirths linked to SSRIs,” said Sue Jordan, Professor at Swansea University in Britain.

Suggesting various measures for preventing SSRI-linked conditions, the researchers said that all women requesting SSRI prescriptions and not just those who are planning pregnancy should be reviewed.

Women who misuse substances or alcohol should be considered as being at higher risk of adverse pregnancy outcomes when prescribed SSRIs.

“Women should not stop taking SSRIs without discussing with their doctor the benefits and risks of SSRIs and alternative nonpharmacological therapies, since good mental health is important for both mother and child,” added Helen Dolk, Professor at Ulster University in Northern Ireland.

For the study, published in the journal PLOS ONE, the team analysed data from more than 500,000 infants in Wales, Norway and Denmark.

Follow @htlifeandstyle for more.

SHARE THIS ARTICLE ON
Close Story
SHARE
Story Saved
OPEN APP
×
Saved Articles
My Reads
Sign out
New Delhi 0C
Monday, October 25, 2021